Article Information
History
- April 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Samuel B Snider, MD*,A,†,
- Ibrahim Migdady, MD*,A,
- Sarah L LaRoseA,
- Morgan E MckeownA,
- Robert W Regenhardt, MD PhDB,
- Pui Man Rosalind Lai, MDC,
- Henrikas VaitkeviciusD, MD and
- Rose DuC, MD PhD
- ADivision of Neurocritical Care, Department of Neurology, Brigham and Women’s Hospital, Boston MA
- BDepartments of Neurosurgery and Neurology, Massachusetts General Hospital, Boston, MA
- CDepartment of Neurosurgery, Brigham and Women’s Hospital, Boston MA
- DMarinus Pharmaceuticals, Radnor, PA
- ↵†Corresponding Author:
Samuel B. Snider, Division of Neurocritical Care, Department of Neurology, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115, Phone: 857-307-2391; email: ssnider{at}bwh.harvard.edu
↵* Authors contributed equally
Posted April 23, 2021.
Vasospasm severity is associated with cerebral infarction after subarachnoid hemorrhage
